Physician profile
Benjamin L Rawson
NPI 1902889397
$1,941.44
in general payments reported to CMS, 2019-2025
19 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $284 · 2021: $610 · 2022: $431 · 2023: $201 · 2024: $59.36 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $374.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $539.48 | 2019-2022 | |
| Abbvie INC. | $374.96 | 2021-2023 | |
| Horizon Therapeutics Plc | $337.74 | 2020-2022 | |
| Pacira Therapeutics, INC. | $215.59 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $79.48 | 2022 | |
| Si-Bone, INC. | $55.37 | 2025 | |
| Teleflex LLC | $54.76 | 2022-2025 | Arrow |
| Ultragenyx Pharmaceutical INC. | $52.75 | 2019-2020 | |
| Bioventus LLC | $32.55 | 2020 | |
| Relievant Medsystems, INC. | $28.26 | 2023 | Intracept |
| Depuy Synthes Sales INC. | $27.60 | 2025 | Orthovisc, Monovisc |
| Scilex Pharmaceuticals INC. | $26.56 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $24.82 | 2024 | Belbuca |
| Biohaven Pharmaceuticals, INC. | $18.48 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $17.44 | 2024 | Exparel, Zilretta, Iovera |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16.96 | 2022 | |
| Ibsa Pharma INC. | $13.77 | 2021 | |
| Foundation Fusion Solutions, LLC | $13.04 | 2025 | |
| Biodelivery Sciences International, INC. | $11.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Rawson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.